American Century Companies’s Organogenesis Holdings ORGO Stock Holding History

American Century Companies's ORGO Position: Q2 2026 in Review

American Century Companies reduced its Organogenesis Holdings (ORGO) stake by 14% in Q2 2026, selling an estimated $57.7K and leaving 144,761 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

American Century Companies first reported a position in ORGO in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.07M in Q2 2023. 93 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

• American Century Companies held 144,761 shares of Organogenesis Holdings worth $352K as of Q2 2026.
• American Century Companies sold 23,611 Organogenesis Holdings shares in Q2 2026, an estimated $57.7K.
• Organogenesis Holdings made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2673 holding.
• American Century Companies first reported a position in Organogenesis Holdings in Q2 2022 and has held it in 17 quarters since.
• American Century Companies's Organogenesis Holdings position peaked at $1.07M in Q2 2023.
• 93 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.